AMATIRAN
BY : KUNTO AJI
Bm E A
memahami hati wanita aku
Am D G
selamanya amatiran
Intro : G
G C
kadang dia ingin sendiri
Am G
tapi harus ditemani
G C
mana yang harus ku ikuti
A D
persimpangan penuh misteri
G C
kompleks dan keindahannya
A G
yang membuatku jatuh hati
G C
dalam belukar pikirannya
A D
ku mencoba tuk mengerti
G A/C# C
huuu katakan padaku
G A/C# C
hauuu jelaskan padaku
G A/C# C
oohuuu katakan padaku
G A/C# C
hauuu jelaskan padaku
Bm E A
memahami hati wanita aku
Am D G
selamanya amatiran
G c
lebih baik ku bertanya
Am G
daripada ku gagal lagi
G C
bertanya pada siapa
A D
karena dia pun tak mengerti
G A/C# C
huuu katakan padaku
G A/C# C
hauuu jelaskan padaku
G A/C# C
oohuuu katakan padaku
G A/C# C
hauuu jelaskan padaku
Bm E A
memahami hati wanita aku
Am D G
selamanya amatiran
D# Dm G
wanita cantik mulia
D# Dm G# G
di bawah kakinya terdapat terdapat surga
F Em A
berulang kali aku mencoba
F Em A
mengerti hatinya tak bisa
A B D
(huuu katakan padaku) katakan padaku
A B D
(hauuu jelaskan padaku) jelaskan padaku
A B D
(oooh huuu katakan padaku) yeeee
A B D
(hauuu jelaskan padaku) jelaskan padaku
C#m F# B
memahami hati wanita aku
C#m F# B
memahami hati wanita aku
Bm E A
selamanya amatiran
A B/A D/A
yeeee oooh
A B/A D/A
selamanya amatiran selamanya amatiran
A B/A D/A
selamanya amatiran aku selamanya amatiran
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment